BTK Inhibitors for the First-Line Treatment of CLL
Embedded Files
Dr. Laurie Sehn discusses the first-line treatment of CLL using BTKis with Dr Jennifer Brown.
14 minutes
BTK Inhibitors for the Treatment of RR CLL
Dr. Laurie Sehn discusses the treatment of RR CLL using BTKis with Dr Jennifer Brown.
10 minutes
BTK Inhibitors for the Treatment of FL
Dr. Laurie Sehn discusses the treatment of MCL using BTKis with Dr Judith Trotman.
10 minutes
BTK Inhibitors for the Treatment of WM
Dr. Laurie Sehn discusses the treatment of WM using BTKis with Dr Judith Trotman.
12 minutes
Mixed Phenotype Hereditary Transthyretin Amyloidosis
Mixed Phenotype Hereditary Transthyretin Amyloidosis
Dr. Diego Delgado discusses how to manage patients with mixed phenotype hereditary transthyretin amyloidosis
13 minutes
Amyloïdose à Transthyrétine Héréditaire à Phénotype Mixte
Amyloïdose à Transthyrétine Héréditaire à Phénotype Mixte
Dre Geneviève Matte discutera de la prise en charge des patients atteints d'amyloïdose à transthyrétine héréditaire à phénotype mixte
13 minutes
Management of Peripheral Neuropathy with BV
Management of Peripheral Neuropathy with BV
In this episode, Dr. Michael Chu discusses the management of peripheral neuropathy with the use of brentuximab vedotin in the first-line treatment of cHL.
20 minutes
Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cHL
Prise en charge de la PN associée au BV utilisé pour le traitement de première intention du cHL
Dr Christopher Lemieux discute la PN associée au BV utilisé pour la traitement de cHL.
15 minutes
ASH 2024 - Updates on the Treatment of CLL
ASH 2024 - Updates on the Treatment of CLL
In this episode, Dr. Versha Banerji and Dr. Jennifer Brown discuss key presentations on the treatment of CLL presented at ASH.
28 minutes
Integrating Non-Covalent BTK Inhibitors in CLL:
Navigating a Rapidly Evolving Treatment Landscape
In this episode, Dr. Versha Banerji discusses the role of non-covalent BTK inhibitors for the treatment of CLL.
18 minutes
EHA 2024 - Updates on the Treatment of CLL
EHA 2024 - Updates on the Treatment of CLL
In this episode, Dr. Versha Banerji, Dr. Sarit Assouline & Dr. Chris Hillis discuss key oral abstracts in CLL presented at EHA with an emphasis on their impact on clinical practice in Canada.
46 minutes
Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective
Management of Cutaneous Squamous Cell Carcinoma (cSCC): A Surgeon’s Perspective
In this episode, Dr. Mark Taylor discusses the surgical implications for the treatment of cSCC.
25 minutes
Immunotherapy for Kidney Transplant Patients with Skin Cancer
Immunotherapy for Kidney Transplant Patients with Skin Cancer
In this episode, Dr. Evan Lipson discusses the use of immunotherapy for patients with skin cancer who have had a kidney transplant.
22 minutes
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep1 - Unmet Needs
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep1 - Unmet Needs
This episode with Dr. Normand Blais discusses the unmet treatment needs for la/mUC in the 1L setting in Canada.
11 minutes
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep2 - 1L Treatment
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep2 - 1L Treatment
This episode with Dr. Terence Friedlander discusses the 1L treatment of la/mUC.
15 minutes
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep3 - Case Discussion
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep3 - Case Discussion
This episode with Dr. Srikala Sridhar presents a clinical case on the treatment of la/mUC.
8 minutes
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep4 - Round Table Discussion
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep4 - Round Table Discussion
In this fourth episode, Drs Normand Blais, Terence Friedlander, and Srikala Sridhar provide their perspective in a round table discussion.
27 minutes
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep5 - ESMO 2023: Discussion on 1L LA/mUC
Video Capsule Series - First Line la/mUC Evolving Treatment Strategies: S2 Ep5 - ESMO 2023: Discussion on 1L LA/mUC
In this fifth episode, Dr. Thomas Powles, Dr. Normand Blais, Dr. Srikala Sridhar, and Dr. Bernie Eigl discuss the impact of data on 1L la/mUC presented at ESMO 2023.
34 minutes
Transcript_Panel Discussion. CCOLD.pdfLive from CCOLD: Treatment of CLL
Live from CCOLD: Treatment of CLL
Live from the CCOLD meeting in Banff, Alberta, we discuss the treatment of CLL with Dr. Laurie Sehn (BC Cancer), Dr. Matthew Davids, (Dana Farber) and Dr. Constantine Tam (University of Melbourne).
Transcript available.
31 minutes
Treatment of COVID-19 with Evusheld: A Canadian Perspective on the TACKLE Trial
Treatment of COVID-19 with Evusheld: A Canadian Perspective on the TACKLE Trial
Dr. Zain Chagla presents a summary of the TACKLE trial and a Canadian perspective on Evusheld for the treatment of COVID-19.
17 minutes
**Funding provided by BeiGene ULC, Sanofi-Aventis Canada, Seagen Canada, AstraZeneca, Merck
Report abuse